Anadys Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company dedicated to improving patient care by developing novel medicines in the areas of hepatitis C and oncology. For the treatment of chronic hepatitis C, the Company is developing two potentially complementary agents, ANA598, a non-nucleoside polymerase inhibitor and ANA773, an oral TLR7 agonist prodrug. The Company is also developing ANA773 for the treatment of cancer.
Company Details
- Employees
- 10
- Phone
- (858)530-3600
- Industry
- Medical Practices
- NAICS
-
Ambulatory Health Care ServicesOffices of Other Health PractitionersOutpatient Care CentersOther Ambulatory Health Care ServicesOffices of All Other Health PractitionersOutpatient Mental Health and Substance Abuse CentersAll Other Ambulatory Health Care ServicesOffices of PodiatristsBlood and Organ BanksAll Other Miscellaneous Ambulatory Health Care Services
- Website
- modapharma.com
- Keywords
- Modafinil and Armodafinil.
Anadys Pharmaceuticals Questions
Anadys Pharmaceuticals's helpline number is (858)530-3600
Anadys Pharmaceuticals's website is modapharma.com
Anadys Pharmaceuticals's LinkedIn profile is https://www.linkedin.com/company/anadys-pharmaceuticals
Anadys Pharmaceuticals has
10 employees.
View email and phone details for 10
employees at Anadys Pharmaceuticals.
Anadys Pharmaceuticals's industry is
Medical Practices
Anadys Pharmaceuticals's top competitors are
Biogen,
Exelixis,
Discovery Partners International, Inc.,
Chemveda Life Sciences India,
Bioduro,
Gilead Sciences,
V2m® Capital, Llc,
Dainippon Sumitomo Pharma America Holdings, Inc.,
Cltl Led Solutions Llc,
Idenix Pharmaceuticals S.r.l..
Anadys Pharmaceuticals's categories are Medical Practices
